Avanos Medical, Inc. Revenue 2012–2025
Avanos Medical, Inc. reported $701.20M of revenue for fiscal 2025. That was 1.9% higher than fiscal 2024. Compared with fiscal 2020, the change was -1.9%.
| Fiscal year | Revenue | Change (YoY) |
|---|---|---|
| FY 2025 | $701.20M | +1.9% |
| FY 2024 | $687.80M | +2.2% |
| FY 2023 | $673.30M | -17.9% |
| FY 2022 | $820.00M | +39.7% |
| FY 2021 | $587.00M | -17.9% |
| FY 2020 | $714.80M | +2.5% |
| FY 2019 | $697.60M | +6.9% |
| FY 2018 | $652.30M | +6.7% |
| FY 2017 | $611.60M | +8.0% |
| FY 2016 | $566.20M | +11.2% |
| FY 2015 | $509.00M | -69.6% |
| FY 2014 | $1.67B | -0.3% |
| FY 2013 | $1.68B | -0.4% |
| FY 2012 | $1.68B | — |
Source: Avanos Medical, Inc. SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open AVNS 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Avanos Medical, Inc. reported $701.20M of revenue for fiscal 2025. That was 1.9% higher than fiscal 2024. Compared with fiscal 2020, the change was -1.9%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Avanos Medical, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeAvanos Medical, Inc. — frequently asked questions
What is Avanos Medical, Inc.'s revenue?
Avanos Medical, Inc. (AVNS) reported revenue of $701.20M for fiscal year 2025, per its SEC filings.
How has Avanos Medical, Inc.'s revenue changed over time?
Between fiscal 2012 and 2025, AVNS's revenue declined at roughly 6.5% per year (compound annual rate), from $1.68B to $701.20M.
Where does this data come from?
Figures are computed from Avanos Medical, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.